Pharmaceutisch Weekblad

, Volume 6, Issue 2, pp 91–95 | Cite as

Pitfalls in the determination of unbound carbamazepine concentrations in plasma

  • J. J. H. M. Lohman
  • F. W. H. M. Merkus
  • G. M. P. J. Costongs
  • E. P. J. M. H. Hegtermans
  • P. M. Hooymans
Original Articles


The usefulness of three simple, commercially available ultrafiltration systems [Centriflo CF25 (A), Centriflo CF50A (B) and Ultrafree (C)] in determining concentrations of unbound carbamazepine in plasma was tested. The concentrations of carbamazepine measured in the first fractions of the ultrafiltrate were low, probably as a result of binding of the drug to the ultrafiltration system. The amount of this binding decreased in the order A > B > C. When using A and B, the first portion of ultrafiltrate obtained after centrifuging for 15 minutes must therefore be discarded. Using the Ultrafree filters this was not necessary. Plasma proteins were found to pass through the Ultrafree filter membrane when more than 0.7 ml ultrafiltrate was collected. Comparison of the ultrafiltration methods with equilibrium dialysis showed a good correlation: r=0.96 (A), r=0.97 (B) and r=0.98 (C). However, in the carbamazepine plasma concentration range 2.5–10.0 μg/ml, significantly lower free fractions were measured with the Centriflo cones. The free fractions measured were: 0.28–0.30 (equilibrium dialysis), 0.17–0.18 (A), 0.22–0.24 (B) and 0.29–0.30 (C). The time required to collect the ultrafiltrate was 30 minutes (A and B) and 2 hours (C).


Public Health Internal Medicine Plasma Concentration Carbamazepine Plasma Protein 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Koch-Weser J, Sellers EM. Binding of drugs to serum albumin (first of two parts). N Engl J Med 1976;294:311–6.PubMedGoogle Scholar
  2. 2.
    Lindup WE, Orme MCL'E. Plasma protein binding of drugs. Br Med J 1981;282:212–4.Google Scholar
  3. 3.
    Bogaert MG. Eiwitbinding van farmaca en monitoring van plasmaspiegels. Pharm Weekbl 1981;116:885–7.Google Scholar
  4. 4.
    Cramer JA, Mattson RH. A simple method to obtain unbound antiepileptic drugs in blood. Ther Drug Monit 1982;4:107–8.PubMedGoogle Scholar
  5. 5.
    Di Salle E, Pacifici GM, Morselli PL. Studies on plasma protein binding of carbamazepine. Pharmacol Res Commun 1974;6:193–202.PubMedGoogle Scholar
  6. 6.
    Rawlins MD, Collste P, Bertilsson L, Palmér L. Distribution and elimination kinetics of carbamazepine in man. Eur J Clin Pharmacol 1975;8:91–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Hooper WD, Dubetz DK, Bochner F, et al. Plasma protein binding of carbamazepine. Clin Pharmacol Ther 1975;17:433–40.PubMedGoogle Scholar
  8. 8.
    Westenberg HGM, Van der Kleijn E, Oei TT, De Zeeuw RA. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva. Clin Pharmacol Ther 1978;23:320–8.PubMedGoogle Scholar
  9. 9.
    Paxton JW, Donald RA. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum. Clin Pharmacol Ther 1980;28:695–702.PubMedGoogle Scholar
  10. 10.
    Westenberg HGM, De Zeeuw RA. Rapid and sensitive liquid Chromatographic determination of carbamazepine suitable for use in monitoring multiple-drug anticonvulsant therapy. J Chromatogr 1976;118:217–24.CrossRefPubMedGoogle Scholar
  11. 11.
    Kurz H, Trunk H, Weitz B. Evaluation of methods to determine protein-binding of drugs. Arzneim Forsch 1977;27:1373–80.Google Scholar
  12. 12.
    Scholtan W. Bestimmungsmethoden und Gesetzmässigkeiten der Serumproteinbindung von Arzneimitteln. Arzneim Forsch 1978;28:1037–47.Google Scholar
  13. 13.
    Rowland M. Plasma protein binding and therapeutic drug monitoring. Ther Drug Monit 1980;2:29–37.PubMedGoogle Scholar
  14. 14.
    Behm HL, Wagner JG. Errors in interpretation of data from equilibrium dialysis protein binding experiments. Res Commun Chem Pathol Pharmacol 1979;26:145–60.PubMedGoogle Scholar
  15. 15.
    Kinget R, Bontinck AM, Herbots H. Problems of dialysis techniques in the study of macromolecule binding of drugs. Int J Pharm 1979;3:65–72.CrossRefGoogle Scholar
  16. 16.
    Van der Giesen WF, Wilting J. New aspects of free drug concentration determination in human serum with equilibrium dialysis. Methods Find Exp Clin Pharmacol 1982;4:417–23.PubMedGoogle Scholar
  17. 17.
    Cronin M, Hammad N. Effect of buffer composition on free drug concentrations by equilibrium dialysis [Abstract]. Clin Pharmacol Ther 1982;31:214.Google Scholar
  18. 18.
    Vallner JJ, Speir Jr WA, Kolbeck RC, Harrison GN, Brandsome Jr ED. Effect of pH on binding of theophylline to serum proteins. Am Rev Respir Dis 1979;120:83–6.PubMedGoogle Scholar
  19. 19.
    Shaw LM, Fields L, Mayock R. Factors influencing theophylline serum protein binding. Clin Pharmacol Ther 1982;32:490–6.PubMedGoogle Scholar
  20. 20.
    Whitlam JB, Brown KF. Ultrafiltration in serum protein binding determinations. J Pharm Sci 1981;70:146–50.PubMedGoogle Scholar
  21. 21.
    Tasker RAR, Nakatsu K. Factors affecting ultrafiltration-assessed values for drug binding. Clin Chem 1982;28:1244–6.PubMedGoogle Scholar
  22. 22.
    Judd RL, Pesce AJ. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. Clin Chem 1982;28:1726–7.PubMedGoogle Scholar
  23. 23.
    Sophianopoulos JA, Durham SJ, Sophianopoulos AJ, Ragsdale HL, Cropper WP. Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out. Arch Biochem Biophys 1978;187:132–7.CrossRefPubMedGoogle Scholar
  24. 24.
    Jung D, Mayersohn M, Perrier D. The ‘Ultra-free’ ultrafiltration technique compared with equilibrium dialysis for determination of unbound thiopental concentrations in serum. Clin Chem 1981;27:166–8.PubMedGoogle Scholar
  25. 25.
    Moss GA. Letter to the editor. Ther Drug Monit 1980;2:431.PubMedGoogle Scholar

Copyright information

© Royal Dutch Association for Advancement of Pharmacy 1984

Authors and Affiliations

  • J. J. H. M. Lohman
    • 1
  • F. W. H. M. Merkus
    • 1
    • 3
  • G. M. P. J. Costongs
    • 2
  • E. P. J. M. H. Hegtermans
    • 3
  • P. M. Hooymans
    • 1
  1. 1.Department of Clinical PharmacyHospital SittardBK SittardThe Netherlands
  2. 2.Department of Clinical Chemistry and HematologyHospital SittardBK SittardThe Netherlands
  3. 3.Department of BiopharmaceuticsUniversity of AmsterdamTV AmsterdamThe Netherlands

Personalised recommendations